Patents by Inventor Motoki Takagi

Motoki Takagi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240135541
    Abstract: A microscope image of a cultured cell cluster derived from a cancer specimen of a patient is acquired. A measured value of a gene expression level of the cluster is acquired. Based on the image, a morphological representation identifiably expressing, by a vector quantity of a plurality of dimensions, a morphological difference between a group of cell clusters cultured from the same cancer specimen and a group of cell clusters cultured from another cancer specimen is acquired. The acquired morphological representation is input to a function, which is obtained by fitting the measured value with respect to the morphological representation, to acquire a prediction value of the gene expression level. Prediction accuracy is estimated based on the prediction value and the measured value. Based on the estimated prediction accuracy, a gene related to a morphological change of the cell cluster is extracted as a gene candidate.
    Type: Application
    Filed: October 12, 2023
    Publication date: April 25, 2024
    Applicants: Evident Corporation, FUKUSHIMA MEDICAL UNIVERSITY
    Inventors: Kosuke TAKAGI, Motoki TAKAGI, Kazuhito GODA
  • Patent number: 11441822
    Abstract: An air conditioner is provided with a refrigerant circuit that has a first refrigerant path to which a compressor, a first utilization-side heat exchanger, a first expansion valve, and a heat source-side heat exchanger are connected in order. A control unit controls the compressor and the first expansion valve. When the control unit receives a request for high-temperature air that temporarily increases the temperature of the hot air blown out through the first utilization-side heat exchanger, the control unit changes the control of the first expansion valve so that the temperature of a refrigerant that flows through the first utilization-side heat exchanger increases.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: September 13, 2022
    Assignee: DAIKIN INDUSTRIES, LTD.
    Inventor: Motoki Takagi
  • Publication number: 20200166233
    Abstract: Provided is an air conditioner that can sufficiently increase a temperature of hot air when receiving a request for high-temperature air that temporarily increases the temperature of the hot air to be blown out. A refrigerant circuit has a first refrigerant path to which a compressor, a first utilization-side heat exchanger (121), a first expansion valve (131), and a heat source-side heat exchanger are connected in order. A control unit controls the compressor and the first expansion valve (131). When the control unit receives the request for high-temperature air that temporarily increases the temperature of the hot air blown out through the first utilization-side heat exchanger (121), the control unit changes the control of the first expansion valve (131) so that the temperature of a refrigerant that flows through the first utilization-side heat exchanger (121) increases.
    Type: Application
    Filed: July 26, 2018
    Publication date: May 28, 2020
    Inventor: Motoki TAKAGI
  • Patent number: 10113783
    Abstract: An air conditioning machine is provided by which refrigerant collected into an outdoor heat exchanger is suppressed from counter-flowing through a discharge hole of a compressor toward a side of an indoor heat exchanger after the end of a pump down operation. The air conditioning machine includes a refrigerant circuit, a refrigerant leakage sensor that senses leakage of the flammable refrigerant from the refrigerant circuit, and a control unit that carries out a pump down operation for accumulating the flammable refrigerant in the outdoor heat exchanger when the leakage of the flammable refrigerant is sensed. At the end of the pump down operation, the pump down operation control unit controls the compressor so that the compression member stops at a position where the compression member overlaps at least a portion of the discharge hole when viewed in an axial direction of the cylinder chamber.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: October 30, 2018
    Assignee: Daikin Industries, Ltd.
    Inventor: Motoki Takagi
  • Publication number: 20180142931
    Abstract: An air conditioning machine is provided by which a refrigerant collected into an outdoor heat exchanger can be suppressed from counter-flowing through a discharge hole of a compressor toward a side of an indoor heat exchanger in a refrigerant circuit after an end of a pump down operation. The air conditioning machine includes a refrigerant circuit, a refrigerant leakage sensing unit that senses leakage of the flammable refrigerant from the refrigerant circuit, and a pump down operation control unit that carries out the pump down operation for accumulating the flammable refrigerant in the outdoor heat exchanger in the refrigerant circuit when the refrigerant leakage sensing unit senses the leakage of the flammable refrigerant. The compressor includes a cylinder chamber, a compression member that is placed in the cylinder chamber and that compresses the flammable refrigerant, and a discharge hole through which the flammable refrigerant compressed in the cylinder chamber is discharged.
    Type: Application
    Filed: June 29, 2016
    Publication date: May 24, 2018
    Applicant: DAIKIN INDUSTRIES, LTD.
    Inventor: Motoki TAKAGI
  • Patent number: 8809296
    Abstract: The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.
    Type: Grant
    Filed: September 27, 2012
    Date of Patent: August 19, 2014
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Publication number: 20140179769
    Abstract: The present inventors discovered that although suppressing expression of the RecQ1 gene, a RecQ helicase family gene, shows suppressive effects on cell proliferation in cancer cells, such effects are not observed in human TIG3 cells (a normal diploid fibroblast cell line), which are normal cells. Hence, the present inventors discovered that siRNAs against RecQ1 gene have cancer cell-specific cell proliferation-suppressing effects that are mediated by suppression of the expression of said gene.
    Type: Application
    Filed: February 26, 2014
    Publication date: June 26, 2014
    Applicant: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Patent number: 8703930
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: April 22, 2014
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Publication number: 20130245097
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Application
    Filed: May 22, 2013
    Publication date: September 19, 2013
    Applicant: GENECARE RESEARCH INSTITUTE CO., LTD.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Patent number: 8470798
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: June 25, 2013
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Patent number: 8314073
    Abstract: The present inventors discovered that although suppressing expression of the RecQ1 gene, a RecQ helicase family gene, shows suppressive effects on cell proliferation in cancer cells, such effects are not observed in human TIG3 cells (a normal diploid fibroblast cell line), which are normal cells. Hence, the present inventors discovered that siRNAs against RecQ1 gene have cancer cell-specific cell proliferation-suppressing effects that are mediated by suppression of the expression of said gene.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: November 20, 2012
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Patent number: 8299044
    Abstract: The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: October 30, 2012
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Publication number: 20120225928
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 6, 2012
    Applicant: Genecare Research Instiute Co., Ltd.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Patent number: 8193332
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 5, 2012
    Assignee: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Publication number: 20100168209
    Abstract: The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 1, 2010
    Applicant: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Publication number: 20090215867
    Abstract: The present inventors discovered that although suppressing expression of the RecQ1 gene, a RecQ helicase family gene, shows suppressive effects on cell proliferation in cancer cells, such effects are not observed in human TIG3 cells (a normal diploid fibroblast cell line), which are normal cells. Hence, the present inventors discovered that siRNAs against RecQ1 gene have cancer cell-specific cell proliferation-suppressing effects that are mediated by suppression of the expression of said gene.
    Type: Application
    Filed: November 17, 2005
    Publication date: August 27, 2009
    Applicant: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato
  • Publication number: 20090028861
    Abstract: The present inventors discovered that inhibition of the expression of various genes associated with chromosome stabilization induces cancer cell-specific apoptosis and inhibits cell proliferation. Compounds that inhibit expression of a gene associated with chromosome stabilization or inhibit the function of a protein encoded by such a gene are thought to have cancer cell-specific apoptosis-inducing effects.
    Type: Application
    Filed: April 8, 2005
    Publication date: January 29, 2009
    Applicant: Genecare Research Institute Co., Ltd.
    Inventors: Motoki Takagi, Kazunobu Futami, Akira Shimamoto, Yasuhiro Furuichi
  • Publication number: 20070243570
    Abstract: The present invention revealed that by suppressing the expression of the WRN gene, the BLM gene, or the RecQ1 gene, which belong to the RecQ helicase family, apoptosis is induced in various cancer cells and their proliferation is suppressed. Compounds that suppress the expression of RecQ helicase family genes or the functions of RecQ helicase proteins are thought to have the activity of inducing apoptosis.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 18, 2007
    Applicant: Genecare Research Institute Co., Ltd
    Inventors: Motoki Takagi, Akira Shimamoto, Yasuhiro Furuichi, Ayumi Sato